Clinical Trial Update: Eltrombopag vs Standard Front Line Management for Newly Diagnosed Immune Thrombocytopenia (ITP) in Children [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating eltrombopag versus standard frontline management for newly diagnosed immune thrombocytopenia in children has completed, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Immune Thrombocytopenia

Drugs mentioned

• Eltrombopag (eltrombopag)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Immune Thrombocytopenia | Phase 3 | Status: COMPLETED | Results posted: 2025-07-29